Big Banks Continue to be Large Stakeholders in Leap Therapeutics, Inc. (:LPTX)

Based on the lastest quarterly filings, institutions continue to be large stakeholders in Leap Therapeutics, Inc. (:LPTX).  The big banks are holding 62.50% of the shares while company insiders are clinging to 10.06%.  Shares of Leap Therapeutics, Inc. are currently valued at $5.61 with a furture target price of $14.50 according to research brokerages.  

As we move deeper into earnings season, investors may be trying to figure out how to best position the portfolio for the rest of the calendar year. Maybe things haven’t gone as well as planned in the first half of the year, and a few tweaks need to be made to bolster profits in the second half. Closely watching the earnings reports may be a good way to see what companies are getting things right, and what companies have some work to do. Many investors will take notice if a company posts a much larger earnings beat or miss than expected. Not only will the stock most likely become a bit more volatile, but overall interest may be heightened as investors try to piece together the puzzle and figure out why there was such a discrepancy between estimates and actuals. Once the dust settles and the picture becomes a little clearer, investors may be able to properly rotate in or out of a certain name or sector. Finding stocks that look good on paper but have fallen out of favor with certain investors may be a good place to start doing some further number crunching. Locating those overlooked sectors with growth potential might be a good way to uncover those stocks that are ready to make a run. 

Leap Therapeutics, Inc. (:LPTX)’s stock has been a favorite of “smart money” aka institutions, as of late.  Institutions are currently holders of 62.50% of the shares.  On the other hand, company insiders are holding 10.06%.  Leap Therapeutics, Inc.’s stock price currently sits at $5.61.

Let’s take a look at how the stock has been performing recently.  Over the past twelve months, Leap Therapeutics, Inc. (:LPTX)’s stock was 4.65%.  Over the last week of the month, it was 4.48%, -22.45% over the last quarter, and  -3.97% for the past six months. 

Over the past 50 days, Leap Therapeutics, Inc. stock was -31.30% off of the high and -6.42% removed from the low.  Their 52-Week High and Low are noted here.  -45.22% (High), 14.36%, (Low). 

Leap Therapeutics, Inc. (:LPTX)’s RSI (Relative Strength Index) is 35.93.  RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions.

Dedicated investors tend to spend a lot of time trying to decipher the correct procedure for beating the stock market. This may involve figuring out a proper strategy, and deciding which stocks to start with when constructing a portfolio. Building a portfolio does not have to be a frantic race. In fact, not rushing into things may end up putting the investor in a good position to succeed. There are times when tough decisions need to be made when dealing with the equity market. Spending enough time to assess all the possibilities before making an investing decision may pay off down the road. As most investors know, there is no magic formula for coming out a winner in the stock market. Acquiring the most possible knowledge about the markets and individual stocks can play a vital role in the long-term success of the individual investor. 

Another important element to consider is the price target and recommendations from brokerage firm analysts.  On a consensus basis the Street sees the stock heading to 14.50 in the near term.  Based on a 1 to 5 integer scale, analysts have a 1.70 recommendation on the name.

Leave a Reply

Your email address will not be published. Required fields are marked *

*